Basilea Pharmaceutica AG (0QNA.L) LSE

46.40

-0.475(-1.01%)

Updated at September 08 02:38PM

Currency In CHF

Valuation

Market Cap499.91M
Enterprise Value490.88M
P/E Ratio8.19
PEG Ratio0
Price/Sales Ratio2.76
Price/Book Ratio7.85
Enterprise/Revenue2.72
Enterprise/EBITDA8.99

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin0.37
Operating Margin0.29

Management Effectiveness

Return On Assets0.3
Return On Equity1.59

Income Statement

Revenue208.54M
Revenue/Share15.42
Gross Profit169.86M
EBITDA63.13M
Net Income77.59M
Diluted EPS5.6

Balance Sheet

Total Cash120.71M
Total Cash/Share8.93
Total Debt111.67M
Total Debt/Equity1.38
Current Ratio4.85
Book Value Per Share5.99

Price History

52-Week Change4.17
52-Week High51.3
52-Week Low32.2
Moving Average 50 Days35.23
Moving Average 200 Days39.55

Statistics

Average Volume4,885
Shares Outstanding12.29M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A